Published DateClear

Start Date

End Date

Category

• Business1
• Events1
• Pipeline1
• Research1

Organizations

• Bausch + Lomb66
• Eyes On Eyecare51
• Alcon, Inc.45
• American Optometric Association37
• Harrow29
• Glaukos27
• Topcon Healthcare25
• Regeneron24
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• Cell Therapy3
• Clinical Trials3
• Cornea3
• Corneal Transplant2
• CEO1
• Ophthalmology Tech Forum1
• Collaboration1
• Genetic Testing1
• Inherited Retinal Disease1
• Injections1

• Organizations: Emmetrope Ophthalmics (Emmecell)✕

Clear all

Business

Leadership watch: Emmecell, ABO, Outlook, and Heidelberg make changes

Leadership changes are underway in the eyecare space—and we’ve got the latest.

Events

KOLs eye the future of genetic engineering and cell transplantation

Industry leaders from four leading ophthalmic companies debut the latest clinical developments in cell-based therapeutics.

Pipeline

Cell therapy dosing concludes for Emmecell's corneal edema trial

Minimally-invasive cell therapy has been designed to repopulate dysfunctional corneal endothelial cells, potentially eliminating the need for transplantation.

Research

Eversight and Emmecell Biotech partner on advanced regenerative ocular cell therapy

Phase 1b trial will study Emmecell’s minimally-invasive cell therapy as an alternative to transplantation.